RxDoctor Payments DataLook up a doctor →

Scott Haydel, MD

Family Medicine · Houma, LANPI 1720173719

Payments from drug & device makers

$14,778in general payments, 2019–2025

Across 992 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$950
  • Amgen$704
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)168$2,495
Pfizer86$1,324
GSK91$1,167
Lilly USA, LLC85$1,071
Novo Nordisk67$950
Amgen(2 entities)43$704
AstraZeneca25$606
Boehringer Ingelheim47$583
Merck41$529
Kowa Pharmaceuticals America, Inc.32$470
Johnson & Johnson26$358
Astellas Pharma US Inc16$289
Amarin Pharma, Inc.22$282
Sunovion Pharmaceuticals Inc.17$265
Antares Pharma, Inc.13$264
Esperion Therapeutics, Inc.17$263
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$227
Bayer12$193
Mylan Specialty L.p.13$190
Otsuka America Pharmaceutical, Inc.11$189
Jazz Pharmaceuticals Inc.7$152
Vanda Pharmaceuticals Inc.7$147
Takeda Pharmaceuticals U.S.A., Inc.9$133
Exact Sciences6$121
Azurity Pharmaceuticals, Inc.6$106
Sanofi-aventis U.S. LLC7$105
E.r. Squibb & Sons, L.L.C.7$101
Teva Pharmaceuticals USA, Inc.7$94
Smith+Nephew6$94
Axsome Therapeutics, Inc.4$87
Phathom Pharmaceuticals, Inc.6$86
Eisai Inc.5$83
Corium, LLC5$78
Novartis6$78
Supernus Pharmaceuticals, Inc.5$77
Abbott4$70
Biohaven Pharmaceutical Holding Company Ltd.4$63
Atland Pharmaceuticals, LLC1$61
Daiichi Sankyo Inc.3$58
Lundbeck LLC3$49
Viatris Specialty LLC2$47
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$45
Biohaven Pharmaceuticals, Inc.2$37
Seqirus USA Inc2$34
Ironshore Pharmaceuticals Inc.2$31
Sanofi Pasteur Inc.2$30
Hikma Pharmaceuticals USA2$30
Tolmar, Inc.2$28
Tactile Systems Technology Inc2$26
Alfasigma USA, Inc.1$23
Optinose US, Inc.1$21
Boston Scientific1$20
Shield Therapeutics Inc1$18
Nestle Healthcare Nutrition Inc.1$17
Inspire Medical Systems, Inc.1$16
Arbor Pharmaceuticals, Inc.1$15
Paratek Pharmaceuticals, Inc.1$15
Gilead1$15
Sumitomo Pharma America, Inc.1$14
Ironwood Pharmaceuticals, Inc1$13

How this compares

$14,778 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$205,591
Medicare patients
512
Services billed
17,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Houma

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →